,Group,Gilenya_pat,Gilenya_relapse,Gilenya_relapse_rate,Tecfidera_pat,Tecfidera_relapse,Tecfidera_relapse_rate,actual_treatment,expect_Gilenya_relapse_rate,expect_Tecfidera_relapse_rate,expect_treatment
training,lowest 35%,497,45,0.0905432595573441,440,90,0.204545454545455,-0.11400219498811,0.0928531941425912,0.196327761313331,-0.10347456717074
training,middle 30%,378,32,0.0846560846560847,426,44,0.103286384976526,-0.0186303003204412,0.0806905607696947,0.113168498713421,-0.0324779379437262
training,highest 35%,463,77,0.166306695464363,474,54,0.113924050632911,0.0523826448314515,0.155260743700195,0.123983496954714,0.0312772467454809
test,lowest 50%,173,21,0.121387283236994,162,21,0.12962962962963,-0.00824234639263541,0.0830106167111868,0.170112855632611,-0.0871022389214239
test,highest 50%,163,22,0.134969325153374,172,22,0.127906976744186,0.00706234840918818,0.125633337257448,0.10937695618708,0.0162563810703684
